Cetraxate hydrochloride
Code | Size | Price |
---|
TAR-T19763-5mg | 5mg | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-1mL | 1 mL * 10 mM (in DMSO) | £147.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-10mg | 10mg | £149.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-25mg | 25mg | £230.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-50mg | 50mg | £369.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-100mg | 100mg | £550.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19763-500mg | 500mg | £1,083.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
CAS:
27724-96-5
Formula:
C17H24ClNO4
Molecular Weight:
341.83
Pathway:
Cell Cycle/Checkpoint; Metabolism
Purity:
0.9823
SMILES:
Cl.NCC1CCC(CC1)C(=O)Oc1ccc(CCC(O)=O)cc1
Target:
Serine/threonin kinase
References
1. Oka M, Ichinose M, Fujishiro M, Omata M. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. Nihon Rinsho. 2005 Nov;63 Suppl 11:461-4. Japanese. PubMed PMID: 16363579.
2. Kubota K, Shimizu N, Nozaki K, et al. Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients. Dig Dis Sci. 2005 May;50(5):842-6.
3. Wu CJ, Hsu PI, et al. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. J Chin Med Assoc. 2004 Apr;67(4):161-7. PubMed PMID: 15244013.
4. Katagiri F, Sato Y, Itoh H, Takeyama M. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma. J Pharm Pharmacol. 2004 Apr;56(4):557-61.